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Lysosomes are key acidic Ca2+ stores. The principle Ca2+-permeable channels of the lysosome are TRP mucolipins
(TRPMLs) and NAADP-regulated two-pore channels (TPCs). Recent studies, reviewed in this collection, have linked
numerous neurodegenerative diseases to both gain and loss of function of TRPMLs/TPCs, as well as to defects in
acidic Ca2+ store content. These diseases span rare lysosomal storage disorders such as Mucolipidosis Type IV
and Niemann–Pick disease, type C, through to more common ones such as Alzheimer and Parkinson disease.
Cellular phenotypes, underpinned by endo-lysosomal trafficking defects, are reversed by chemical or molecular
targeting of TRPMLs and TPCs. Lysosomal ion channels therefore emerge as potential druggable targets in com-
batting neurodegeneration.
Keywords: Ca2+, Lysosomes, Acidic Ca2+ Stores, TPCN1, TPCN2, MCOLN1, NAADP, Phosphatidylinositol-3,5-
Bisphosphate, Neurodegeneration.
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INTRODUCTION
According to the textbook, Ca2+ stores are synonymous
with the endoplasmic reticulum (ER). And, certainly by
volume, the ER is no doubt the largest store of Ca2+ oft
mobilised to regulate numerous cellular events (Berridge,
2002). But acidic organelles such as lysosomes have also
emerged as important Ca2+ stores despite their relatively
small volume (Christensen et al., 2002; Morgan et al.,
2011; Patel and Docampo, 2010).
Lysosomes are H+- and Ca2+-replete organelles—that
together with lysosome-related organelles, endosomes,
secretory vesicles and the more distantly related acido-
calcisomes and vacuoles (found in organisms outside of
the animal kingdom)—constitute the acidic Ca2+ stores
E-mail: patel.s@ucl.ac.uk
(Patel et al., 2010; Patel and Muallem, 2011). Like the ER,
lysosomes express Ca +-permeable channels and trans-
porters (Patel and Cai, 2015). Strategic positioning of
these organelles in close proximity to the ER (allowing
Ca2+ signals to be amplified or tempered) and other acidic
organelles (facilitating vesicular fusion) offers an alter-
native, versatile means to regulate Ca2+-dependent out-
put (Kilpatrick et al., 2013; Lopez-Sanjurjo et al., 2013;
Melchionda et al., 2016; Pryor et al., 2000; Yamasaki
et al., 2004).
Befitting widespread functional roles for lysosomes
(Xu and Ren, 2015), evidence is now accumulating that
links dysregulated lysosomal Ca2+ channel function to
neurodegenerative disease (Fig. 1). This collection of
reviews summaries this contemporary literature.
DRUGGING ENDO-LYSOSOMAL
Ca2+-PERMEABLE CHANNELS
The archetypal lysosomal ion channel is TRP mucolipin 1
(TRPML1). This channel has attracted much attention
because it is mutated in the childhood neurodegenera-
tive lysosomal storage disorder, Mucolipidosis Type IV
(MLIV) (Bargal et al., 2000). The two-pore channels TPC1
and TPC2 are endo-lysosomal ion channels that have
entered the limelight more recently (Galione et al., 2009;
Grimm et al., 2017; Patel, 2015). Both TRPML1 and TPC2
are targeted to lysosomes via dileucine motifs (Brailoiu
et al., 2010; Vergarajauregui and Puertollano, 2006) and
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Figure 1. Deviant lysosomal Ca2+ signalling in neurodegenera-
tion. Schematic relating dysfunction of Ca2+-permeable channels in
lysosomes (inner perimeter) to neurodegenerative disease (outer
perimeter).
both are Ca2+-permeable (LaPlante et al., 2002; Schieder
et al., 2010). It is however interesting that the ion selec-
tivity of these channels has been subject to controversy
(Marchant and Patel, 2013; Puertollano and Kiselyov,
2009) likely related to the special challenges associated
with characterizing intracellular as opposed to plasma
membrane-targeted channels.
Here, Grimm (2016) discusses the rapidly advancing
pharmacology of TRPMLs, in particular the identification
of TRPML agonists and antagonists (Chen et al., 2014;
Grimm et al., 2010; Samie et al., 2013). The pharmacol-
ogy of TPCs is relatively poorly characterised and lim-
ited to modifiers of voltage-gated Ca2+ and Na+ channels
(Rahman et al., 2014; Sakurai et al., 2015). Neverthe-
less indirect inhibitors such as the antagonists of the Ca2+
mobilising messenger NAADP, a TPC activator, are prov-
ing useful (Davidson et al., 2015; Naylor et al., 2009).
As discussed throughout the reviews in this issue, chem-
ical tools targeting TRPMLs and TPCs are providing new
insights into the function and dysfunction of these chan-
nels in various neurodegenerative contexts.
TRPML1 AND NEURODEGENERATION
The role of TRPML1 in MLIV has been well reviewed and
the reader is referred to recent articles (Ahuja et al., 2016;
Bach et al., 2010; Grimm et al., 2012; Venkatachalam
et al., 2015; Wang et al., 2014). Grimm covers work
demonstrating correction of lysosomal storage in MLIV
fibroblasts by synthetic TRPML agonists (Chen et al.,
2014; Grimm, 2016). This is significant as it opens up
new therapeutic options for forms of the disease where
TRPML1 activity is not completely lost. Notably, growing
evidence suggests that TRPML1 function might also be
compromised in disorders such as Niemann–Pick disease,
type C (NPC) (Shen et al., 2012), a distinct lysosomal stor-
age disorder, and Alzheimer’s disease (Lee et al., 2015)
amongst others. Here, reviews by Lloyd-Evans (2016) and
Feng and Yang (2016) provide overviews of the relevant
literature.
It was using various models of NPC that a clear
link between lysosomal Ca2+ and lysosomal storage was
uncovered (Lloyd-Evans et al., 2008). Lysosomal Ca2+
levels measured directly (using endocytosed Ca2+ indi-
cators) or indirectly (through cytosolic Ca2+ signals in
response to the lysosomotropic agent GPN) suggested that
they were lower in NPC, and that lysosomal Ca2+ deple-
tion was an early step in the pathogenesis. Although sup-
ported by independent studies (reviewed by Lloyd-Evans
(2016)), more recent findings suggest that TRPML1 chan-
nels are inhibited by the accumulation of sphingomyelins
in NPC rather than a reduction in stored Ca2+ (Shen
et al., 2012). However, whether reductions in total Ca2+
were masked by secondary ER Ca2+ release (Kilpatrick
et al., 2013) remains a formal possibility. Nevertheless,
both studies concur that lysosomal Ca2+ signalling is
inhibited in the disease (Lloyd-Evans et al., 2008; Shen
et al., 2012). Importantly, boosting activity of endoge-
nous TRPML1 with a synthetic TRPML agonist in NPC
reversed lysosomal storage (Shen et al., 2012). Chemical
activation of TRPML1 has also been reported to clear lyso-
somal amyloid -peptides and sphingomyelin in cellular
models of HIV dementia (Bae et al., 2014). However,
in these cells TRPML channels appeared to be hyperac-
tive. It is worth mentioning that TRPML1 activity in these
studies (Bae et al., 2014; Shen et al., 2012) was mea-
sured using a genetically-encoded Ca2+ indicator fused
to TRPML1 (Zhong et al., 2016b). Although elegant, the
approach requires overexpression of TRPML1 which as
shown recently triggers Ca2+ influx and ER Ca2+ release
(Kilpatrick et al., 2016b). Such coupling might confound
interpretation of the resulting signals.
Both TRPMLs and TPCs are regulated by the
endo-lysosomal phosphoinositide, phosphatidylinositol-
3,5-bisphosphate (PI(3,5)P2 (Dong et al., 2010; Jha et al.,
2014; Wang et al., 2012). Levels of this lipid are governed
by PIKfyve and FIG4 (Dove et al., 2009). Mutations in the
gene encoding FIG4 lower PI(3,5)P2 levels and are associ-
ated with Charcot-Marie-Tooth peripheral neuropathy type
4J (CMT4J) (Chow et al., 2007) as well as a number of
other disorders. In FIG4 knockout cells, lysosomal Ca2+
levels measured using Calcium Orange were elevated (Zou
et al., 2015). As in NPC and HIV dementia models, chem-
ical activation of TRPMLs normalised lysosomal dysfunc-
tion. These findings again suggest compromised TRPML
activity, presumably due to PI(3,5)P2 deficiency that results
MESSENGER 5, 24–29, 2016 25
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in Ca2+ accumulation within lysosomes. Elevated lysoso-
mal Ca2+ levels upon FIG4 depletion are reminiscent of
the findings in Drosophila upon knockout of its single
mucolipin homologue (Wong et al., 2012) and in some
TRPML1-deficicent mammalian cells (Cao et al., 2015b)
but not others (Soyombo et al., 2006).
Finally, recent work by Lee et al. show that lysosomal
Ca2+ levels are reduced in cells lacking the Alzheimer
disease-linked gene, Presenilin 1 (PSEN1) (Lee et al.,
2015). These findings are consistent with earlier findings
in PSEN1 and PSEN2 double knockout cells (Coen et al.,
2012). Interestingly, endogenous Ca2+ responses to a syn-
thetic TRPML agonist were paradoxically enhanced upon
PSEN1 knockout, pointing to a model whereby the hyper-
activation of TRPML1 lowers steady state lysosomal Ca2+
levels (Lee et al., 2015). In accord, reduced lysosomal
Ca2+ and the associated elevation in cytosolic Ca2+ were
reversed by knockdown of TRPML1. Interestingly, treat-
ment of PSEN1-deficient cells with an NAADP antagonist
was also effective in resetting Ca2+ homeostasis but knock-
down of TPC2 was not. These data suggest complex inter-
play between TRPML and NAADP signalling possibly
involving TPC1. Normalising Ca2+ levels however failed
to reverse proteolytic and autophagic defects in PSEN1-
deficient cells. Rather the associated changes in lysosomal
pH upon PSEN knockout (albeit disputed) appeared to be
more functionally relevant (Lee et al., 2015).
In sum, TRPML1 has been implicated in a number of
neurodegenerative diseases with evidence for both a gain
and loss of function in activity associated with complex
effects on lysosomal Ca2+ content.
TPC2 AND NEURODEGENERATION
Like, TRPML1, TPC2 has also been linked to neu-
rodegeneration. Reviews in this issue by both Hilfiker
and colleagues (Rivero-Rios et al., 2016), and Kilpatrick
(2016) discuss defective lysosomal Ca2+ signalling
in Parkinson disease. Initial overexpression studies of
the Parkinson disease-linked protein LRRK2 identified
autophagic defects (Gomez-Suaga et al., 2012), adding
to what is now a body of literature implicating endo-
lysosomal dysfunction in the disease (Abeliovich and
Gitler, 2016). Importantly, these defects were recapitulated
upon NAADP treatment and reversed by chemically antag-
onising NAADP action or by overexpressing a dominant-
negative TPC2 construct (Gomez-Suaga et al., 2012).
Subsequent work by Hockey et al. identified endo-
lysosomal morphology defects in Parkinson disease patient
fibroblasts carrying the G2019S mutation in LRRK2
(Hockey et al., 2015). Again, these defects were reversed
by NAADP antagonism including a novel analogue better
suited for in vivo studies. Chemical or molecular inhibi-
tion of TPCs, local Ca2+ fluxes, PI(3,5)P2 signalling, and
the TPC-interactor Rab7 (Lin-Moshier et al., 2014) all
reversed endo-lysosomal morphology defects, further high-
lighting this axis as a potential therapeutic target (Hockey
et al., 2015). Like in PSEN1-deficent cells, these data point
to a gain of function in lysosomal Ca2+ signalling. In
accord, NAADP-evoked Ca2+ signals were enhanced upon
mutation of LRRK2. Steady state lysosomal Ca2+ levels
were not measured in LRRK2-linked Parkinson disease.
However, as further discussed by Kilpatrick (2016), lyso-
somal Ca2+ levels were reduced in GBA1-linked Parkinson
disease (Kilpatrick et al., 2016a). This form of the dis-
ease is due to mutations in glucocerebrosidase, a lysosomal
enzyme, and is highly relevant because recessive muta-
tions in GBA1 cause Gaucher disease, another lysosomal
storage disorder.
Rare lysosomal storage disorders and more common
neurodegenerative disease thus seem to be intimately
linked through defects in lysosomal Ca2+.
A ROLE FOR OTHER LYSOSOMAL
CHANNELS IN NEURODEGENERATION?
Whereas TRPMLs and TPCs localise predominantly to
the endo-lysosomal system, other Ca2+-permeable chan-
nels traditionally thought of as plasma membrane proteins
are also found within lysosomes. These include TRPM2
(Lange et al., 2009), P2X4 (Qureshi et al., 2007) and more
recently the voltage-gated Ca2+ channel, Cav2.1 (Tian
et al., 2015) and TRPA1 (Shang et al., 2016). This raises
the possibility that these channels might also (de) regu-
late lysosomal Ca2+ signalling. Indeed, autophagic defects
in neurons from the leaner mouse have been ascribed to
lysosomal Cav2.1 (Tian et al., 2015) which might link
defective lysosomal Ca2+ signalling to neurodegenerative
diseases associated with Cav2.1 mutation such as episodic
ataxia 2. By the same logic, perhaps lysosomal P2X4 and
TRPA1 contribute to neuropathic pain which is often asso-
ciated with neurodegeneration.
Although not a Ca2+ channel, the big-conductance
Ca2+-activated K+ (BK) channel, Slo1 also localises to
lysosomes, interacts with TRPML1 and is thought to pro-
vide a counter current to sustain Ca2+ release (Cao et al.,
2015b). Notably, overexpression or chemical activation
of Slo1 reverses storage phenotypes in patient fibroblasts
from several lysosomal storage disorders including NPC
and MLIV (Cao et al., 2015b; Zhong et al., 2016a).
The number of lysosomal ion channels potentially rele-
vant for neurodegeneration is steadily growing.
LYSOSOMAL Ca2+-PERMEABLE CHANNELS
AND ENDO-LYSOSOMAL TRAFFICKING
Ca2+-regulates endo-lysosome fusion and lysosome ref-
ormation necessary for endo-lysosomal trafficking (Pryor
et al., 2000). Thus, the identification of an endo-lysosomal
26 MESSENGER 5, 24–29, 2016
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Ca2+ permeable channel (TRPML1) immediately sug-
gested a mechanism to explain aberrant lysosome mor-
phology and the mis-trafficking of lipids characteristic
upon loss of channel function (in MLIV) (Pryor et al.,
2006). However, pinpointing the exact subcellular ‘lesion’
is challenging due to the difficulties in assaying these
dynamic processes in live cells and the interconnected and
heterogeneous nature of the endocytic system.
In the case of TPC2, it is clear that gain-of func-
tion, be it pathological (manifest in Parkinson disease)
(Hockey et al., 2015) or experimental (upon TPC2 overex-
pression) (Lin-Moshier et al., 2014), enlarges lysosomes.
This points to a fusogenic role for TPC2 within the endo-
lysosomal system, as discussed in the review by Hilficker
(Rivero-Rios et al., 2016). Indeed, TPCs associate with
the fusogenic machinery (Grimm et al., 2014; Lin-Moshier
et al., 2014; Marchant and Patel, 2015). Similar roles
for P2X4 in endo-lysosome fusion (Cao et al., 2015a)
and Cav2.1 in endo-lysosome/autophagosome fusion (Tian
et al., 2015) have also been advanced. In the case of
TRPML1 however, it is loss of function that consistently
results in lysosome enlargement. Might this result due to
a block in fission. In accord, fission is altered in FIG4-
deficient cells in a TRPML-dependent manner (Zou et al.,
2015). But potential fusogenic roles for TRPML1 in the
context of endo-lysosome/amphisome fusion in Drosophila
(Wong et al., 2012) and lysosomal exocytosis in mam-
malian cells (Samie et al., 2013) should not be ignored.
In sum, lysosomal channel dysfunction s associated
with endo-lysosomal trafficking defects but the mechanis-
tic details are still hazy.
SCOPE
Growing evidence links dysregulated lysosomal Ca2+ sig-
nalling to neurodegeneration. Currently available small
molecule activators and inhibitors, together with molecu-
lar manipulations, have been used with promising effect to
reverse cellular phenotypes and identify the relevant target
channels. But mechanistically, potentiation or inhibition of
target channels does not always intuitively correlate with
steady-state levels of lysosomal Ca2+. This underscores the
need for rigorous analyses of lysosomal Ca2+ signals and
better methods to do so. Indeed, flux of other ions such
as Fe2+ through TRPML1 (Dong et al., 2008) and likely
TPCs too (Fernandez et al., 2016) might also be function-
ally relevant. Whilst, there is no doubt that channel dys-
function is manifest in vesicular trafficking defects, further
work is required to more precisely delineate the affected
processes. Finally, considering potential roles for lysoso-
mal ion channels in regulating non-vesicular traffic may
also be of merit given physical contact of endo-lysosomes
with other organelles (Kilpatrick et al., 2013) and the reg-
ulation of such contact by stored Ca2+ (Kilpatrick et al.,
2017). These considerations will no doubt advance the
ultimate aim of developing novel mechanism-based ther-
apeutics for tackling neurodegeneration in our ever-aging
population.
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